LORAZ Drug Patent Profile
✉ Email this page to a colleague
When do Loraz patents expire, and when can generic versions of Loraz launch?
Loraz is a drug marketed by Quantum Pharmics, Amneal Pharms, Chartwell Molecular, Hikma, Lupin Ltd, Pharm Assoc, Bedford, Dr Reddys, Endo Operations, Epic Pharma Llc, Hospira, Intl Medication Sys, Rising, Watson Labs, Roxane, Am Therap, Anda Repository, Ani Pharms, Aurolife Pharma Llc, Chartwell Rx, Halsey, Leading, Mutual Pharm, Oxford Pharms, Par Pharm, Sandoz, Sun Pharm Inds Ltd, Superpharm, Usl Pharma, Warner Chilcott, and Bedford Labs. and is included in sixty-seven NDAs.
The generic ingredient in LORAZ is lorazepam. There are eleven drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Loraz
A generic version of LORAZ was approved as lorazepam by SANDOZ on April 21st, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LORAZ?
- What are the global sales for LORAZ?
- What is Average Wholesale Price for LORAZ?
Summary for LORAZ
| US Patents: | 0 |
| Applicants: | 31 |
| NDAs: | 67 |
| Raw Ingredient (Bulk) Api Vendors: | 49 |
| Patent Applications: | 4,475 |
| Drug Prices: | Drug price information for LORAZ |
| Drug Sales Revenues: | Drug sales revenues for LORAZ |
| DailyMed Link: | LORAZ at DailyMed |
US Patents and Regulatory Information for LORAZ
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | LORAZEPAM | lorazepam | TABLET;ORAL | 077657-002 | Mar 16, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bedford Labs | LORAZEPAM PRESERVATIVE FREE | lorazepam | INJECTABLE;INJECTION | 077074-002 | Jul 13, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Amneal Pharms | LORAZEPAM | lorazepam | TABLET;ORAL | 078826-001 | Jun 23, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rising | LORAZEPAM | lorazepam | INJECTABLE;INJECTION | 200542-001 | Apr 28, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Usl Pharma | LORAZEPAM | lorazepam | TABLET;ORAL | 070539-001 | Dec 22, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | LORAZEPAM | lorazepam | TABLET;ORAL | 077396-003 | Dec 13, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Leading | LORAZEPAM | lorazepam | TABLET;ORAL | 078203-002 | Jul 30, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
